Cargando…

The role of P-wave dispersion in dystrophic and thalassemic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Russo, Vincenzo, Papa, Andrea A, Nigro, Gerardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965703/ https://www.ncbi.nlm.nih.gov/pubmed/29844900 http://dx.doi.org/10.1177/2048004016663011

Ejemplares similares

Polycystic ovary syndrome and arrhythmic risk: the role of comorbidities and the prevalence of interatrial block
por: Russo, Vincenzo, et al.
Publicado: (2016)

Hepatitis C virus infection in thalassemic patients with and without insulin dependent diabetes
por: De Sanctis, Vincenzo, et al.
Publicado: (2015)

Transcatheter Aortic Valve Replacement (TAVR) in Thalassemic Patients
por: Mehta, Yatin, et al.
Publicado: (2022)

Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice
por: Mattè, Alessandro, et al.
Publicado: (2023)

P-wave dispersion and left ventricular diastolic dysfunction in hypertension
por: Ertem, Ahmet Göktuğ, et al.
Publicado: (2015)

Dystrophic calcification in the masseter muscle
por: Walulik, Agata, et al.
Publicado: (2023)

Dystrophic cardiomyopathy: role of the cardiac myofilaments
por: George, Thomas G., et al.
Publicado: (2023)

P‐wave dispersion is a vectorial phenomenon: Is it time to change minds?
por: Carmona Puerta, Raimundo, et al.
Publicado: (2022)

P-wave dispersion in different clinical situations: Expanding list with resembling mechanisms
por: Okutucu, Sercan, et al.
Publicado: (2017)

Is there a relationship between disease duration and P-wave dispersion in patients with psoriasis?
por: Sen, Bilge Bulbul, et al.
Publicado: (2013)

How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion
por: Acampa, Maurizio, et al.
Publicado: (2017)

P-wave dispersion in vitiligo patients
por: Nasiri, Soheila, et al.
Publicado: (2019)

Emerging Therapies for Dystrophic Cardiomyopathy
por: Garry, Daniel J., et al.
Publicado: (2019)

Thalassemic Child Presenting with Anosmia due to COVID-19
por: Marhaeni, Wulandewi, et al.
Publicado: (2020)

Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patients
por: Russo, Vincenzo, et al.
Publicado: (2012)

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
por: Diociaiuti, Andrea, et al.
Publicado: (2019)

Left Ventricular Mechanical Dispersion for the Better Risk Stratification of Patients With Hypertrophic Cardiomyopathy: Is It Possible?
por: Mohsenibadalabadi, Reza, et al.
Publicado: (2021)

Dystrophic Cardiomyopathy—Potential Role of Calcium in Pathogenesis, Treatment and Novel Therapies
por: Johnstone, Victoria P. A., et al.
Publicado: (2017)

Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results
por: PALLADINO, ALBERTO, et al.
Publicado: (2019)

P1586: COMPARISON OF FREQUENCY OF TRANSFUSION RELATED COMPLICATIONS IN THALASSEMIC AND NON-THALASSEMIC PATIENTS RECEIVING NON LEUKODEPLETED RED CELL CONCENTRATE.
por: Imran, Tanzeel, et al.
Publicado: (2023)

Cardiac resynchronization improves heart failure in one patient with Myotonic Dystrophy type 1. A case report
por: RUSSO, VINCENZO, et al.
Publicado: (2012)

Histologic Sequelae of Apical Hypertrophic Cardiomyopathy: Dystrophic Calcification
por: Saba, Shahryar G, et al.
Publicado: (2017)

The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator
por: Russo, Vincenzo, et al.
Publicado: (2020)

Desferioximine induced Ototoxicity in Thalassemic patients
por: Vir, Dharam, et al.
Publicado: (2010)

Dominant Dystrophic Epidermolysis Bullosa with a Mutation in COL7A1 Confirmed by Diagnostic Exome Sequencing
por: Won, Sang-Hyeon, et al.
Publicado: (2022)

A de novo missense mutation in the NC1 domain of type VII collagen leads to dystrophic epidermolysis bullosa
por: Cheng, Ping, et al.
Publicado: (2022)

Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype
por: Tsuda, Takeshi, et al.
Publicado: (2017)

Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement
por: Russo, Vincenzo, et al.
Publicado: (2014)

The Antioxidant Effect of Erythropoietin on Thalassemic Blood Cells
por: Amer, Johnny, et al.
Publicado: (2010)

The Reproductive Behavior of Families with Thalassemic Children in Hormozgan
por: Safari Moradabadi, Ali, et al.
Publicado: (2015)

Outcome of iron reduction therapy in ex-thalassemics
por: Aboobacker, Fouzia N., et al.
Publicado: (2021)

Perception of Parents of Thalassemic Child to Thalassemia in Pakistan
por: Saleem, Noman, et al.
Publicado: (2021)

Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
por: Fujita, Y., et al.
Publicado: (2021)

Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
por: Heier, Christopher R, et al.
Publicado: (2019)

Efficiency of quantification of cardiac electrical heterogeneity: via QT dispersion, transmural dispersion, or both
por: Tokatli, A, et al.
Publicado: (2015)

Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave
por: Atripaldi, Luigi, et al.
Publicado: (2021)

P1458: MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.
por: Matte’, Alessandro, et al.
Publicado: (2023)

Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients
por: Fianza, Pandji Irani, et al.
Publicado: (2021)

Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial
por: Chiaverini, Christine, et al.
Publicado: (2016)

Worsening of Cardiomyopathy Using Deflazacort in an Animal Model Rescued by Gene Therapy
por: Rotundo, Ida Luisa, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p9ibk5dh4b41d4uavub3feve7u